Callitas Health (Callitas Health) Accounts Payable : $0.47 Mil (As of Sep. 2020)

View and export this data going back to 2008. Start your Free Trial

What is Callitas Health Accounts Payable?

Callitas Health's Accounts Payable for the quarter that ended in Sep. 2020 was $0.47 Mil.

Callitas Health's quarterly Accounts Payable increased from Mar. 2020 ($0.42 Mil) to Jun. 2020 ($0.49 Mil) but then declined from Jun. 2020 ($0.49 Mil) to Sep. 2020 ($0.47 Mil).

Callitas Health's annual Accounts Payable declined from Dec. 2017 ($0.68 Mil) to Dec. 2018 ($0.58 Mil) and declined from Dec. 2018 ($0.58 Mil) to Dec. 2019 ($0.45 Mil).

Callitas Health Accounts Payable Historical Data

The historical data trend for Callitas Health's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Callitas Health Accounts Payable Chart

Callitas Health Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Accounts Payable

Get a 7-Day Free Trial

0.53

0.68

0.58

0.45

Callitas Health Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
Accounts Payable	Get a 7-Day Free Trial															-	0.45	0.42	0.49	0.47

Callitas Health Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Callitas Health Accounts Payable Related Terms

Thank you for viewing the detailed overview of Callitas Health's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Callitas Health (Callitas Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Callitas Health Inc (OTCPK:MPHMF) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

734 - 1055 Dunsmuir Street, Vancouver, BC, CAN, V7X 1B1

Website

http://www.callitas.com

Callitas Health Inc is a clinical-stage company. It is engaged in developing technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications. The company's products offering includes ToConceive, C-103 Reformulated Orlistat, and Extrinsa. ToConceive is a fertility enhancing moisturizer. It is clinically proven to increase a woman's own natural conception lubrication, called transudate, to aid in conception. Orlistat is FDA-approved for weight management and sold by Roche as Xenical (prescription) and by GlaxoSmithKline as alli. Extrinsa focuses on women with orgasm and arousal difficulties. The topical, local, and the non-systemic product is also non-hormonal and does not affect the central nervous system.